Neurological impacts of COVID-19

Authors
Category Primary study
Year 2021
COVID-19 is a pandemic respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected more than 72 million people and claimed 1.6 million lives worldwide (15 Dec 2020). Recent studies suggest a neurotropic element of COVID-19 infections, as 36.4% (78/214) of patients exhibit neurological abnormalities, including headache, acute ischemic stroke, epilepsy, encephalitis, encephalopathy, ataxia, anosmia, ageusia, and acute disseminated encephalomyelitis
Epistemonikos ID: 50b3199c5da097c7295a840948ae23d6361c51ff
First added on: Aug 23, 2021